Atlas Trials

Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation

Clinical trial NCT00623701 · COMPLETED

Trial details

NCT number
NCT00623701
Sponsor
Allergopharma GmbH & Co. KG
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
AllergyRhinitisConjunctivitis
Start date
2008-03-01
Primary completion
2011-10-01
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.